Category: Patent Litigation
-
Public version of Nokia v. Amazon ITC ruling in multimedia SEP case holds e-commerce giant responsible for unlicensed status
The public redacted version of a trade judge’s December 2024 ruling shows that Amazon was far from prevailing over Nokia on a FRAND defense.
-
Catalyst and Teva Pharmaceuticals settle patent dispute over rare-disease drug, but fight for orphan treatment not over yet
Nasadaq-listed Catalyst sees shares rise by 18% following the settlement, which grants Teva a license from February 2035.
-
World’s top EV battery maker CATL files fresh infringement lawsuit, adds to China’s lengthy battery patent docket
Contemporary Amperex Technology Co., Limited’s action marks its seventh patent infringement suit against local rival China Aviation Lithium Battery, with a cumulative claim of over 700 million Chinese yuan (US$ 95.6 million) in damages.
-
Netgear settles WiFi 6 standard-essential patent dispute with Huawei, takes license to Sisvel pool between Unified Patent Court and Munich I Regional Court rulings
Netgear and Huawei have filed a motion to stay the U.S: litigation started by the router maker in response to enforcement actions in the UPC and German courts.
-
Unprecedented major delay at USITC for remedy recommendation after Lenovo was found to infringe four Ericsson SEPs
While ITC judges typically issue their recommendations on remedy (i.e., U.S. import ban) near-simultaneously with their rulings, it will now potentially take more than two months in an Ericsson-Lenovo SEP case.
-
Huawei v. Netgear was only the second UPC anti-antisuit motion this month: a near-simultaneous one may have targeted Xiaomi
The UPC’s Munich LD has now published its December 11, 2024 anti-antisuit injunction in Huawei v. Netgear. It turns out that a similar motion was brought in a different case slightly before Huawei’s filing.
-
Abbott fends off Dexcom’s push for patent royalties as multi-jurisdictional litigation settles with 10-year zero-zero patent peace over glucose monitoring devices
Abbott and Dexcom have settled a multi-jurisdictional patent dispute over glucose monitoring devices. It appears that Dexcom failed to achieve its goal of getting Abbott to pay.
-
Netgear obeys UPC and German anti-antisuit injunctions, yet attempts to thwart Huawei’s patent enforcement through interim license
Netgear has withdrawn its request for a U.S. antisuit injunction against Huawei’s UPC and German cases, but keeps pursuing an interim license.
-
UPC’s Court of Appeal throws out Alexion’s appeals against Amgen and Samsung Bioepis over validity doubts, reveals €100M value of each dispute
The UPC’s Court of Appeal rejects Alexion’s appeals of decisions to deny preliminary injunctions against Amgen and Samsung Bioepis, where the value of the dispute was set at €100M for each case.
-
Japan’s Nippon Shinyaku vows to fight on in U.S. drug dispute against Sarepta Therapeutics, despite heavy $115 million blow
The Japanese pharma company initiated the drug patent litigation in 2021, but the case eventually boomeranged and a District of Delaware verdict last week ultimately handed Sarepta the win.